Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases

J Nanobiotechnology. 2024 May 15;22(1):252. doi: 10.1186/s12951-024-02501-9.

Abstract

With increasing proportion of the elderly in the population, age-related diseases (ARD) lead to a considerable healthcare burden to society. Prevention and treatment of ARD can decrease the negative impact of aging and the burden of disease. The aging rate is closely associated with the production of high levels of reactive oxygen species (ROS). ROS-mediated oxidative stress in aging triggers aging-related changes through lipid peroxidation, protein oxidation, and DNA oxidation. Antioxidants can control autoxidation by scavenging free radicals or inhibiting their formation, thereby reducing oxidative stress. Benefiting from significant advances in nanotechnology, a large number of nanomaterials with ROS-scavenging capabilities have been developed. ROS-scavenging nanomaterials can be divided into two categories: nanomaterials as carriers for delivering ROS-scavenging drugs, and nanomaterials themselves with ROS-scavenging activity. This study summarizes the current advances in ROS-scavenging nanomaterials for prevention and treatment of ARD, highlights the potential mechanisms of the nanomaterials used and discusses the challenges and prospects for their applications.

Keywords: Age-related disease; Aging; Antioxidant; Nanomaterials; Reactive oxygen species.

Publication types

  • Review

MeSH terms

  • Aging* / drug effects
  • Animals
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Free Radical Scavengers* / chemistry
  • Free Radical Scavengers* / pharmacology
  • Free Radical Scavengers* / therapeutic use
  • Humans
  • Nanostructures* / chemistry
  • Oxidative Stress* / drug effects
  • Reactive Oxygen Species* / metabolism